Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.

about

The mitosis-specific marker phosphohistone-H3 (PHH3) is an independent prognosticator in uterine smooth muscle tumours: an outcome-based study.Minichromosome maintenance protein 2 correlates with the malignant status and regulates proliferation and cell cycle in lung squamous cell carcinoma

P2860

Q40466987-F1E9F760-C07B-4AF2-8755-57DAB273208A Q58735649-800F96FD-D73C-49B6-BEFC-1F8429CFE627

P2860

Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.

Item

http://www.wikidata.org/entity/Q40362934

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Expression of cell cycle marke ...... ocally advanced breast cancer.

@en

type

Item

label

Expression of cell cycle marke ...... ocally advanced breast cancer.

@en

prefLabel

Expression of cell cycle marke ...... ocally advanced breast cancer.

@en

P1476

Expression of cell cycle marke ...... ocally advanced breast cancer.

@en

P2093

Anna-Mária Tőkés

http://www.w3.org/2001/XMLSchema#string

Gergő Kiszner

http://www.w3.org/2001/XMLSchema#string

Gyöngyvér Szentmártoni

http://www.w3.org/2001/XMLSchema#string

Janina Kulka

http://www.w3.org/2001/XMLSchema#string

Lilla Madaras

http://www.w3.org/2001/XMLSchema#string

Magdolna Dank

http://www.w3.org/2001/XMLSchema#string

Tibor Krenács

http://www.w3.org/2001/XMLSchema#string

Tímea Tőkés

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

Proliferation is the strongest prognosticator in node-negative breast cancer: significance, error sources, alternatives and comparison with molecular prognostic markers

Relationship between tumour shrinkage and reduction in Ki67 expression after primary chemotherapy in human breast cancer

Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

Digital immunohistochemistry wizard: image analysis-assisted stereology tool to produce reference data set for calibration and quality control.

The Ki-67 protein: fascinating forms and an unknown function.

A methodology to ensure and improve accuracy of Ki67 labelling index estimation by automated digital image analysis in breast cancer tissue

A novel model for Ki67 assessment in breast cancer.

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer.

Ki67, chemotherapy response, and prognosis in breast cancer patients receiving neoadjuvant treatment.

P2888

s00428-016-1925-x

P304

675-686

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00428-016-1925-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

468

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1009198143

http://www.w3.org/2001/XMLSchema#string

P698

27026269

http://www.w3.org/2001/XMLSchema#string

Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.

about

P2860

P2860

Expression of cell cycle markers is predictive of the response to primary systemic therapy of locally advanced breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698